Katharina C. Kaehler

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen, Diana Miao, Bastian Schilling et al. · Science · 2015 · 3K citations · Full text

Medicine, Cancer Biology, Oncology +17

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Caroline Voskens, Simone M. Goldinger, Carmen Loquai et al. · PLoS ONE · 2013 · 470 citations · Full text

Medicine, Oncology, Pharmacology +16

An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma

Reinhard Dummer, Axel Hauschild, Juergen C. Becker et al. · Clinical Cancer Research · 2008 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients

Teresa Amaral, Felix Kiecker, Sarah Schaefer et al. · Journal for ImmunoTherapy of Cancer · 2020 · 88 citations · Full text

Medicine, Immunology, Oncology +17

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

Axel Hauschild, Uwe Trefzer, Claus Garbe et al. · Melanoma Research · 2008 · 80 citations

Medicine, Oncology, Pharmacology +16